| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
University Department of Growth and Reproduction (R.B.J., A.J.), and University Department of Neonatology (S.V., G.G.), Rigshospitalet, DK-2100 Copenhagen, Denmark; Department of Gynaecology and Obstetrics (T.L.), Holbaek Sygehus, Sygehus Vestsjaelland, DK-4300 Holbaek, Denmark; and Division of Endocrinology and Metabolism (J.V.), Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905
Address all correspondence and requests for reprints to: Rikke Beck Jensen, M.D., University Department of Growth and Reproduction, Rigshospitalet, Section 5064, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark. E-mail: rikke.beck{at}dadlnet.dk.
| Abstract |
|---|
|
|
|---|
Objective: Our objective was to evaluate the influence of fetal growth rate on male reproductive function.
Design: We conducted a follow-up study of a prospective study with data on third trimester fetal growth velocity and birth weight.
Setting: The study was conducted at Copenhagen University Hospital.
Participants: Fifty-two healthy adolescent males participated. They were divided into those born appropriate for gestational age (AGA) and SGA, with or without intrauterine growth restriction.
Main Outcome Measures: Pubertal stage, testicular size, and reproductive hormones were determined. Overnight 20-min LH and FSH profiles and overnight urine LH and FSH were determined in an additional study (n = 30).
Results: No significant differences were found in testosterone levels (19.2 vs. 18.9 nmol/liter), inhibin B levels (186.5 vs. 188.0 pg/ml), or LH/testosterone ratio (0.15 vs. 0.18) between AGA and SGA, respectively. No significant differences in overnight secretory patterns of gonadotropins or testicular size and morphology were determined by ultrasonography between AGA and SGA. Fetal growth velocity did not influence any of the reproductive hormone levels. Overnight urinary LH and FSH excretion correlated statistically significantly with overnight LH (r = 0.50; P = 0.02) and FSH (r = 0.44; P = 0.04) secretion, respectively.
Conclusion: Poor third trimester growth and/or low birth weight had no effect on subsequent male reproductive hormones. Contrasting a previous study, we found no difference in testosterone or inhibin B levels between SGA and AGA, suggesting that testicular function was not impaired in adolescent males born after compromised fetal growth.
| Introduction |
|---|
|
|
|---|
We hypothesized that low birth weight corrected for gestational age and/or IUGR in third trimester of pregnancy may determine the function of the adult pituitary-gonadal axis.
| Subjects and Methods |
|---|
|
|
|---|
|
The study was performed according to the Helsinki II declaration and approved by the local Ethical Committee. Written informed consent was obtained from all participants or from the parents/guardians.
Study design
The participants arrived fasting in the morning, and blood samples were drawn. Height (centimeters) was measured using a stadiometer, and weight (kilograms) was measured on a digital weight scale. The SDS for height and weight were calculated based on a national reference (8). Pubertal stage and testicular size were determined. Testicular size and morphology were determined by ultrasound (9). Pulsatile hormone assessments (n = 30) were carried out during overnight admission where blood samples were collected at 20-min intervals from 2000 to 0800 h. Participants collected urine overnight (12 h).
Biochemical assays
Male reproductive hormones were determined in the morning blood sample. Blood samples were centrifuged, and serum was stored at 20 C until analysis. Assays included: testosterone by time-resolved fluoroimmunoassay (DELFIA; Wallac, Turku, Finland), detection limit 0.23 nmol/liter, and intra- and interassay coefficient of variation (CV) less than 6%; estradiol by RIA (Pantex Corp., Santa Monica, CA), detection limit 18 pmol/liter, intraassay CV less than 8%, interassay CV less than 13%; inhibin B by specific two-sided enzyme immunometric assay from Oxford Bio-Innovation Ltd. (Oxford, UK), sensitivity 18 pg/ml, and intra- and interassay CV less than 12 and 17%, respectively; SHBG by time-resolved immunofluorometric assay (DELFIA; Wallac, Inc.), detection limit 0.23 nmol/liter, intra- and interassay CV less than 5.1%. Free testosterone concentration was calculated using the equation of Vermeulen et al. (10). FSH and LH concentrations were measured by time-resolved immunofluorometric assay (DELFIA; Wallac, Inc.), detection limits 0.06 and 0.05 U/liter, respectively; and intraassay and interassay CV less than 5%.
Urinary LH and FSH
Urine samples (2 ml) were supplemented with 80 µl BSA (25% BSA stock) and 150 µl glycerol and were stored at 20 C until analysis. Urinary LH and urinary FSH concentrations were measured by Delfia immunofluorometric assays (Wallac) (11).
Analysis of pulsatile hormone secretion
A two-component deconvolution analysis was applied to estimate pulsatile LH and FSH secretion in each individual from the overnight profiles, using techniques described previously by Veldhuis and Johnson (12). Preliminary fits of the data were made by a waveform-independent deconvolution methodology (PULSE2) followed by a multiparameter deconvolution methodology. Fixed rapid-phase half-lives and fitted slow-phase half-lives for LH and FSH were used (13, 14). Approximate entropy (ApEn) analysis was calculated (15). ApEn parameters of m = 1 and an r value of 0.35 (35%) of the SD of the individual subject time series were chosen. Higher absolute ApEn denotes greater disorderliness of hormone release, and vice versa, for lower ApEn.
Statistical analysis
The majority of the variables compared were nonnormal distributed; thus the results are provided as median and interquartile range (IQR) and compared by Mann-Whitney U test (level of significance < 0.05). However, the strategic sampling of the study resulted in a skewed distribution of FGV and birth weight (BW) SDS toward lower values, and to counter for this bias a weighting of the underrepresented group in a univariate linear regression analysis was performed. Furthermore, bootstrapped SE of estimates was applied for the calculation of confidence intervals of the weighted estimates. In the univariate or multivariate (general linear model) regression analyses, the nonnormal distributed dependent variables were transformed to normality before being entered into the model. Because no statistically significant differences were apparent in the regression model, the raw data divided according to BW status (AGA vs. SGA) were presented for the purpose of clarification. The statistical analyses were carried out using the statistical package SPSS (version 14.0; SPSS, Inc., Chicago, IL).
| Results |
|---|
|
|
|---|
|
| Discussion |
|---|
|
|
|---|
The majority of studies exploring the association between low birth weight and pituitary-gonadal axis have focused on female reproductive function. Such studies have suggested that young women born SGA have decreased ovarian hormones (17), reduced ovarian volume, and an increased number of anovulatory cycles (18). For boys there is evidence that low birth weight corrected for gestational age is associated with increased risk of cryptorchidism and hypospadias (2, 19), and furthermore decreased fertility as well as an increased risk of testicular cancer in adult life. The association between SGA and male reproductive hormones has only been evaluated in one former clinical study in which significantly decreased testosterone and elevated LH levels were found in 25 men born SGA (BW < 10th percentile) compared with 24 men born AGA (16). These findings may suggest a primary testicular failure in men born SGA; however, five of the SGA individuals had cryptorchidism at birth, and the control group consisted of 20 patients with constitutional short stature (16). In our similar sized study, it was not possible to detect a statistically significant effect of poor intrauterine growth and/or low birth weight on subsequent male reproductive hormones. In our study, there were no differences in testosterone and inhibin B levels between the two groups, suggesting that low birth weight per se does not influence testicular function. However, genital malformations (like cryptorchidism) associated with SGA may have an effect on subsequent gonadal function.
Our participants were recruited from a large prospective study in which 1000 pregnant women were included consecutively; thus the group may be less selected compared with the group studied by Cicognani et al. (16). Importantly, we found no statistical differences in BW or FGV between the 52 participants and the 74 subjects who declined to participate (nonparticipants). Furthermore, there were no significant differences in basal reproductive hormones or any of the clinical characteristics between the participants with an overnight hormone profile and those who declined. Thus, we do not believe our study is influenced by major selection bias, although this cannot be entirely excluded.
In conclusion, smallness at birth was not associated with adolescent male pituitary-testicular function and, importantly, fetal growth rate in third trimester per se did not influence the outcomes. Further studies are needed to clarify if being born SGA subtly influences male pituitary-gonadal function, as it has been suggested for women born SGA.
| Footnotes |
|---|
First Published Online January 16, 2007
Abbreviations: AGA, Appropriate for gestational age; ApEn, approximate entropy; BW, birth weight; CV, coefficient of variation; FGV, fetal growth velocity; IQR, interquartile range; IUGR, intrauterine growth restriction; SDS, SD score; SGA, small for gestational age.
Received October 26, 2006.
Accepted January 4, 2007.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. B. Ojeda, D. Grigore, and B. T. Alexander Developmental Programming of Hypertension: Insight From Animal Models of Nutritional Manipulation Hypertension, July 1, 2008; 52(1): 44 - 50. [Full Text] [PDF] |
||||
![]() |
L. Aksglaede, R. B. Jensen, E. Carlsen, P. Kok, D. M Keenan, J. Veldhuis, N. E Skakkebaek, and A. Juul Increased basal and pulsatile secretion of FSH and LH in young men with 47,XXY or 46,XX karyotypes. Eur. J. Endocrinol., June 1, 2008; 158(6): 803 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Allvin, C. Ankarberg-Lindgren, H. Fors, and J. Dahlgren Elevated Serum Levels of Estradiol, Dihydrotestosterone, and Inhibin B in Adult Males Born Small for Gestational Age J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1464 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Fowler, S. Cassie, S. M. Rhind, M. J. Brewer, J. M. Collinson, R. G. Lea, P. J. Baker, S. Bhattacharya, and P. J. O'Shaughnessy Maternal Smoking during Pregnancy Specifically Reduces Human Fetal Desert Hedgehog Gene Expression during Testis Development J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 619 - 626. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |